z-logo
open-access-imgOpen Access
Medicaid Patients' Access To New Drugs
Author(s) -
Henry G. Grabowski
Publication year - 1988
Publication title -
health affairs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.837
H-Index - 178
eISSN - 2694-233X
pISSN - 0278-2715
DOI - 10.1377/hlthaff.7.5.102
Subject(s) - formulary , medicaid , medicine , medical prescription , population , health care , family medicine , government (linguistics) , public health , business , public administration , political science , environmental health , nursing , law , linguistics , philosophy
Prologue: Prescription drugs have demonstrated an awesome capacity to ameliorate pain and wage war against infectious diseases. But, unlike most other medical services and products, outpatient drugs are generally not covered either by private health insurance or, until its new catastrophic benefit becomes effective. Medicare. About two-thirds of the population pays for its drugs directly out of pocket Only Medicaid, among the large public health financing programs, has provided outpatient drug coverage to eligible beneficiaries. As Medicaid programs have faced increasing pressure to moderate the growth of expenditures, though, some states have created drug formularies to restrict the products for which they will reimburse pharmacists. In this paper, Henry Grabowski addresses the question of how formularies affect the availability of drugs proven safe and efficacious by the Food and Drug Administration. Grabowski received his doctorate in economics from Princeton University in 1967. Since 1972, he has been...

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom